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DEVELOPMENT OF A BLOOD SEPARATION METHOD FOR  
LOW- TO MIDDLE-INCOME COUNTRIES 
BILAL SYED AHMED 
ABSTRACT 
The Covid-19 pandemic has brought to the world’s attention how a pandemic can 
burden hospitals all over the world, especially in regions where the healthcare system is 
already overburdened and low on resources. Low-resource settings would benefit 
considerably from point of care tests that can generate quick results, which would allow 
hospitals and/or clinics to properly allocate resources for treatment. In this thesis, we 
designed a blood separation system that: separates plasma from whole blood efficiently 
and is cheaper and more efficient than the gold standard of centrifugation. The blood 
separation system allows for the pooling and collection of plasma which can then be used 
to run a diagnostic test. A centrifuge separates blood by creating a gravity field generated 
by high-speed rotation. In this study, we used fidget-spinners, toys that can be manually 
spun with the flick of the finger, to generate a gravitational field strong enough to separate 
plasma from whole blood. We also designed an automated spinner, made of affordable 
parts, to make the fidget-spinner method of separating blood more efficient and easier to 
use. The spinner includes a 12V DC motor that can spin at up to 12000 rpm with no load 
and 3D printed parts that attach to the motor and hold the blood samples. Blood volumes 
ranging from 25 – 100 µL were used to test the separation methods. Using the spinner 
manually resulted in a plasma yield of around 30-40% with plasma purity of 65-75%. With 
a motorized spinner, plasma yield and purity were similar to the yield and purity of 
 v 
centrifuged samples. These findings provide support for the feasibility of low resource-
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CHAPTER 1: INTRODUCTION 
         Improving patient outcomes is essential for any developing country’s long term 
social and economic stability. Over the last 100 years, great strides have been made in the 
medical field and life expectancies all around the world have risen. However, over the last 
20 years, the life expectancy rates of many developing countries have become stagnant.1 
Developing countries are burdened with many of the same noncommunicable diseases as 
more developed countries such as heart disease, cancer, and diabetes, while having less 
funding and resources to take on these problems.2 They are further burdened by various 
infectious diseases, which while treatable, still pose a threat to many living in low- or 
middle-income countries. Early-stage treatment is essential in combating diseases before 
they become endemic.3 Diagnostic testing helps providers make well informed decisions 
on what type of therapeutic interventions need to be made. However, public health 
institutions in these regions often lack the resources to adequately test and treat their 
patients on a large enough scale. Many regions in developing countries may lack the high-
end laboratory facilities that are used in developed countries to perform essential diagnostic 
tests.4 Point of care testing (POCT) aims to offer providers and patients in low- and middle-
income countries with a way to test patients rapidly and accurately with minimal 
technology so that people can receive the treatment they need on time. 
         POC testing is becoming an integrated part of many countries’ public health system. 
When accessible and reliable, POCTs can save thousands of lives every year.5 Diagnostic 
testing with rapid or POCTs can be done outside a laboratory facility, and are extremely 
useful for their ease of use, quick turnaround time, portability, reliability, and low cost. 
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They allow for providers to make quick and well-informed decisions regarding a patient’s 
treatment. Therefore, it is essential when designing POCTs to make sure that they are 
compatible and useable for the regions they are likely to be tested in. One aspect of many 
POCTs that should be considered is that many are plasma-based assays.6 Other whole 
blood components can interfere with the assay, and so to run the test properly, plasma must 
first be separated from whole blood.7 In a laboratory setting, this is done using a centrifuge. 
However, centrifuges are often large, heavy, and require high electrical power. While the 
gravitational force generated by the high-speed spinning of a centrifuge is extremely 
effective in separating plasma from whole blood, their lack of portability and feasibility in 
low- to middle-income regions requires us to look elsewhere for blood separation methods. 
Many current blood separation methods use paper-based membranes or microfluidic 
systems to isolate plasma.8 However, there are some limitations to these methods that we 
will shortly discuss in greater detail. In this thesis, we aim to explore methods of blood 
separation that utilize the same principles of centrifuge-based separation but are feasible 
for use in LMIC. This was done using two designs. The first design utilized minimal 
materials and technology to separate plasma from whole blood. The second design included 




CHAPTER 2: BACKGROUND 
2.1 Healthcare in the Developing World 
         At present, developing countries are home to around 90% of the world’s population, 
but only account for around 12% of the world’s public health expenditures.9 The lack of 
strong public health systems in LMIC results in a greater burden on the people living in 
those countries. In LMICs, out-of-pocket spending accounts for 40% of the funding.10 
Economic and infrastructural barriers make it difficult for many people in these regions to 
receive adequate healthcare. Diseases such as obesity, diabetes, and heart disease are 
decreasing in developed countries due to higher awareness and increased treatment. 
However, in LMICs, the rate for these noncommunicable diseases continues to increase.1 
This is a concerning trend, as it further hinders these countries’ ability to treat preventable 
and infectious diseases. In 2019, there were an estimated 229 million new malaria 
infections and 409,000 deaths.11 The vast majority of people living with HIV or AIDS are 
in the developing world.12 Now, as decade long wars and conflicts in various parts of the 
world continue to go on, the global community is faced with a refugee health crisis. Recent 
events such as the COVID-19 pandemic have shown that in a globalized world, public 
health crises in a seemingly faraway country are relevant to everyone.13 It is essential for 
the progress of LMICs and global health that their public health crises are addressed. 
         One way that the gap in medical care can be shortened is by making diagnostic tests 
accessible for people living in LMICs. Being able to detect a disease in its early stages can 
reduce mortality rates, as patients will be able to receive care before their disease 
progresses to a more serious or untreatable stage.14 It also helps saves costs, as treating 
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diseases in later stages is often more expensive and requires more intensive care. 
Biotechnology companies all over the world have the noticed the growing market for POC 
tests. It is estimated that by 2025, the global POC diagnostics market size will reach USD 
50.6 billion compared to the 29.5 billion in 2020.15 Start-ups and large corporations alike 
are developing POC tests for noncommunicable diseases such as heart disease and obesity 
by developing assays for glucose and proteins such as NT-proNB, a biomarker for heart 
disease. They are also developing tests to treat common infectious diseases in the 
developing world such as Hepatitis C, Malaria, Visceral Leishmaniasis, etc.16 For a 
diagnostic test to be effective in the field, it must meet the World Health Organization’s 
ASSURED criteria, as outlined below.3,8  
         It should be affordable and of low cost to manufacture. A POCT must be 
economically viable. 
It should generate sensitive and specific results. If providers are to use a test to make 
treatment decisions, it is essential that the results are accurate and reliable so that patients 
can receive the appropriate care. 
A POCT must be user friendly. Providers should be able to use the POCT with little 
training, and it should require as few steps as possible. 
It should be robust in relation to the setting it is being used. POCTs to be used in 
LMICs should not require refrigeration and should be able to withstand environmental 
conditions. It should have a short turnaround time. Providers should be able to get results 
quickly so that they can make an informed treatment decision while the patient is still 
present. Often in LMICs, patients are not able to make multiple trips to a clinic or testing 
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site in a short period of time, so it is important to make a decision regarding intervention 
during the patients visit, if possible. 
         It should be equipment-free. The diagnostic test should be operable with use of 
minimal equipment since extraneous equipment is not always readily available in LMICs. 
 It should be deliverable to those who need access to POC testing. 
         One of the most difficult aspects of designing an effective POC test is coming up 
with a quick and efficient way to separate plasma from whole blood. The two most 
predominant modes of accomplishing this are lateral flow tests and microfluidic devices. 
Below, we will discuss the advantages and disadvantages of these methods further. 
2.2 Lateral Flow POC Testing 
         Lateral flow tests use the properties of water immunoassays to run rapid diagnostic 
tests for several different applications including pregnancy tests, detection of infectious 
diseases, and screening for cancer-related biomarkers. Lateral flow immunoassays 
(LFIAs), as a general overview, are made of a membrane that can capture the analyte or 
biomarker of interest. Using capillary action, fluid containing the analyte or biomarker is 
transported to the detection section of the strip where antibodies have been placed that react 
to analyte and give a signal dependent on the amount of analyte.17  
         The majority of POCT in the field today are LFIAs. They meet many of the 
requirements listed above and perform well in the settings all around the world. They are 
mainly used in LMICs to detect infectious diseases such as malaria, HIV, hepatitis, 
influenza, other various sexually transmitted diseases, etc.17 Many epidemiological studies 
have shown that POCT often is an improvement over current detection systems in LMICs 
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and can lead to better patient outcomes.4 A study in South Africa showed that testing for 
C-reactive protein (CRP) using a bedside POCT offered better predictive values than the 
laboratory CRP tests that were in place.4,18  
         Although LIFAs are generally effective for POC diagnostic, there are some 
limitations to the technology that could be improved upon. One such limitation is the 
simplicity of their design. While their simplicity makes them viable for use in the field, it 
can sometimes hinder their performance for more complex assays. Designing an LFIA that 
is both accurate and useable is something that researchers try to balance in the development 
of LFIAs. They also can exhibit variable performance due to differences in external 
conditions such as temperature, humidity, and sunlight.19 Another limitation, which is more 
relevant to this thesis, is the fact that often times, LFIAs only work with plasma.6,19 The 
plasma separation system is usually incorporated into the sample pad, which makes it easy 
to use, but can affect the performance of the strip. Paper-based separation membranes can 
sometimes take long to separate plasma from whole blood and can have low yield. If not 
enough plasma makes it through the separation membrane in time, the results will not be 
accurate. This problem is even more pronounced for tests that require an exact amount of 
plasma, such as the POCT for suPAR, a biomarker for respiratory disease. Too little or too 
much plasma can result in inaccurate readings. 
2.3. Microfluidic Systems in POC Testing 
         Microfluidics, although newer to POCT applications than LFIAs, have also shown 
great promise when it comes to diagnostics. They can be incorporated into many other 
laboratory techniques and allow for precise work with small volumes. Microfluidic 
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devices, when used as blood separation tools, have often been proposed to be used in 
conjunction with LFIAs. Plasma pooled form a microfluidic device can be collected 
separately, and exact volumes of plasma can then be used to run a POCT. 
Microfluidic devices can also be used as POC devices themselves. The performance of 
microfluidic devices is often enhanced by including various washing/mixing buffers or 
centrifugal steps at various speeds.20 Microfluidic platforms such as lab-on-a-chip devices 
are being proposed as potential POCTs to be implemented in diagnostic testing. These 
devices often yield very strong results. A lab-on-a-chip device for malaria was shown to 
have a sensitivity of 96.7% and specificity of 100%.21 This level of performance is rarely 
seen with lateral flow tests. 
         While microfluidics can improve POCT performance, there are many barriers that 
prevent them from being implemented on a large scale in the LMICs. The use of automated 
instruments that is often associated with microfluidics is likely the largest barrier. Testing 
sites or clinics in LMICs may often lack the laboratory and/or equipment necessary to get 
the full use of a microfluidic device. Another problem with microfluidic based diagnostic 
tests is that they often take long to run. Whether it is to pool plasma from a blood sample 
or run a test on a lab-on-a-chip type device, it can often take a long time to finally collect 
the sample or get results, making it not ideal for POCT, where providers and patients expect 
more immediate results. 
2.4 Plasma from Whole Blood Separation 
         For many commercially available lateral flow tests, the assays require use of plasma 
as opposed to whole blood. Separating plasma from the other components of blood 
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removes red blood cells (RBC). Blood is made up of four main components: plasma, RBCs, 
white blood cells RBCs, and platelets. Plasma is a liquid component made up of water, 
sugar, fat, salts, and proteins. It usually makes up around 50% of whole blood volume, 
although it can vary by small amounts from person to person. RBCs for many assays, are 
a source of interference. The hemoglobin in RBCs can react with certain proteins either in 
the plasma or on the strip to induce off target reactions that give false signals. It is also 
possible for RBCs to lyse during a diagnostic test. When a RBC lyses, it releases ions and 
other intracellular components that can react with analytes or proteins. This can also 
interfere with the true signal. The removal of red blood cells decreases background noise 
and improves the accuracy of plasma based POCTs.7  
         Centrifugation is the gold standard for blood separation. Centrifuges are machines 
with a rapidly rotating container that spins fast enough to generate a gravitational force that 
will separate a mixture by the density of its components. In the case of whole blood, when 
spun in a centrifuge it’s RBCs will sink to the bottom and the plasma will remain on the 
top. While a centrifuge is effective in separating plasma from whole blood in 10 minutes 
or less while spinning at 2000 RPMs, there reasons listed below explain why it is not 
feasible for use in LMICs. 
o Centrifuges require trained personnel to operate in a laboratory setting. 
o Centrifuges are exceedingly expensive. 
o Centrifuges require a power source. At the POC in low- to middle-income 
region, there is not likely to be a power source suitable for a centrifuge. 
         For the above reasons, a centrifuge can only be operated in a central laboratory. 
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This would require blood to be transported from the POC to a lab in order to use a 
centrifuge for plasma-based diagnostic testing. As previously discussed, an essential 
element of POC testing in LMICs is getting results as soon as possible. Centrifuges cannot 
provide this in our regions of interest, requiring providers and healthcare workers to look 




CHAPTER 3: MATERIALS AND METHODS 
3.1 Fidget Spinner Method 
         For the first blood-separating system design, a fidget spinner manufactured by 
FIGROL was used to isolate plasma from whole blood. A fidget spinner is handheld toy 
made of plastic with a metal center. The center is made of a circular metal encasing that 
contains ball bearings, which allow the fidget spinner to rotate along the vertical axis with 
little applied force. Three arms extend from the center of the fidget spinner and each arm 
has a hole on its end. 
         When testing for blood separation, human whole blood (Research Blood 
Components) was pipetted into Eppendorf tubes and placed in the holes of each arm. The 
fidget spinner was then manually spun for 7–12 minutes. The spinner was held in one hand 
and periodically flicked on by the other hand to maintain an approximate top speed. After 
the time had elapsed, the fidget spinner was allowed to come to a stop. The Eppendorf 
tubes were then removed from the fidget spinner and plasma that had separated from the 
whole blood was decanted from the top of the sedimented mixture. 
3.2 Motorized Spinner Method 
         For the second blood-separating system design, a motor (Auto tool home) 
connected to 3D printed parts was used to isolate plasma from whole blood. The motor was 
a 12-volt DC motor that spins at 12000 rotations per minute (r.p.m.) and draws 0.24 amps 
with no load. The 3D printed parts for this device were printed using polylactic acid (PLA) 
from a Prusa i3 MK3 3D printer. One piece attached to the spinning head of the motor and 
another piece held the motor in place. Two 9-volt batters or four 3-volt batteries (Duracell) 
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were using to power the system. 
         Blood was pipetted into Eppendorf tubes and placed sockets of the 3D printed part 
that attaches to the spinning head of the motor. The motor is then switched on and allowed 
to run for a given amount of time. After the motor has come to a stop, the Eppendorf tubes 
are removed, and plasma is decanted from the top of the sedimented blood mixture. The 
purity of the plasma was evaluated as described in section 3.1. The current draw of the 
motor on the battery under different conditions was evaluated using a multimeter 
(Amprobe).   
3.3 Control Testing with Centrifuge 
         Equal amounts of whole blood were pipetted into Eppendorf tubes and placed in a 
centrifuge, equally spaced apart. According to standard protocols taken from previous 
studies, whole blood was centrifuged at 2000 r.p.m. for 10 minutes. The Eppendorf tubes 
were then removed from the centrifuge and plasma was decanted. It was evaluated for 
purity as described in section 3.1. 
3.4 Purity and Yield Calculations 
The extracted plasma was then analyzed for its yield and purity. The purity was 
determined using a procedure similar to one described in a previous study in which 3 µL 
of a sample are pipetted onto a slide and covered with a cover slip.22 An optical microscope 
(CKX41, Olympus, Tokyo, Japan) was used to observe the blood/plasma samples and 
determine their purity. Five different areas of equal size (0.2 mm2) of the blood/plasma 
sample on the microscope slide were randomly selected. The number of RBCs in this unit 




𝑃𝑢𝑟𝑖𝑡𝑦 = 1 −	𝑅𝐵𝐶𝑠	𝑖𝑛	𝑤ℎ𝑜𝑙𝑒	𝑏𝑙𝑜𝑜𝑑 𝑅𝐵𝐶𝑠	𝑖𝑛	𝑠𝑎𝑚𝑝𝑙𝑒⁄  
The RBCs in whole blood were calculated using the same method. 
 The yield of the plasma samples was determined using a pipette to aliquot the 
plasma samples in small amounts. The volume of each aliquot was added up after all the 
plasma had been accounted for. The assumption was made that plasma accounted for 50% 
of the total blood volume. Based on this assumption, plasma yield was determined by the 





CHAPTER 4: FIDGET SPINNER METHOD OF BLOOD SEPARATION 
4.1. Justification for selection 
         Fidget spinners are small, handheld toys that became popular around the world for 
their simplicity and the interesting way they spin with little applied force. Most handheld 
spinning devices require constant use of a mechanical pump or lever. However, fidget 
spinners with just a flick of one of their arms, can spin fast enough to generate the 
centrifugal force required to separate plasma from whole blood. The ball bearings in the 
center of fidget spinner make this possible. A ball bearing is constructed with an inner and 
outer wall and a number of steel balls in between. The spherical balls make minimal contact 
with the walls due to their shape and roll the race in between the walls to reduce friction as 
the fidget spinner spins. This phenomenon allows for fidget spinners to rotate at high 
speeds with the flick of a finger. 
Fidget spinners are also relatively inexpensive. They cost less than USD 2 but are 
sturdy and can handle the load of three Eppendorf tubes. They are also extremely easy to 
operate, as they are toys designed for children as young as three years old. Their low cost 
and ease of use would allow them to be conveniently purchased and used in LMIC 
healthcare settings. Their size also allows for them to be portable and easily transported to 
settings in which they may be used. The holes located at the ends of each arm of the fidget 
spinner provide a spot for the Eppendorf tubes containing blood samples to be placed. For 
these reasons, it was determined that if proved to be an effective isolator of plasma, fidget 






Figure 1. A schematic describing the steps required in use of the fidget spinner blood 
separation system. A) An Eppendorf tube containing whole blood is inserted into a fidget 
one of the arms of the fidget spinner. B) The fidget spinner is spun manually for a given 
amount of time with the centrifuge tube still in it. C) The tube, after the given time has 
elapsed, is removed from the fidget spinner. D) Plasma is decanted from the mixture in C 





4.2 Results and Discussion for Separation with a Fidget Spinner 
         Blood separation was tested with four different volumes: 25 µL, 50 µL, 75 µL, and 
100 µL. These volumes were determined to be a reasonable range of collected whole blood 
from non-invasive blood drawing methods. The whole blood was inserted into the fidget 
spinner arms as described in Section 3.1 and the fidget spinner was spun for varying times 
from 7 – 15 minutes. The results below show the yield of the blood as a result of time spun. 
It was determined that 10 minutes was the optimal spinning time, as there was little 
improvement in separation after 10 minutes. Also, in discussion with other researchers who 
design sustainable medical technology for LMICs, it was determined that blood separation 
should ideally not go beyond 10 minutes, since some lateral flow assays can take an 
additional 20 minutes to run. It is important to not add on large amounts of time to a POCT 





Figure 2. The percent yield of the four different sample loads was evaluated for its 
separation as a function of how long the fidget spinner was being spun for. 
 
 
         The plasma yield and purity were further compared in relation to sample volume. 
It was determined that sample size did not affect the yield. There was also no difference in 
plasma purity as a result of sample volume. The low yield was likely due to the fact the 
fidget spinner was not able to spin at a high enough r.p.m. to separate more than roughly 







Figure 3. A) Percent yield of plasma with whole blood loaded onto the fidget spinner at 
volumes of 25, 50, 75, and 100 µL with n = 10. This sample was spun for 10 minutes before 
being stopped and separated. B) Purity of plasma with whole blood loaded onto the fidget 
spinner at volumes of 25, 50, 75, and 100 µL with n = 10. This sample was spun for 10 
minutes before being stopped and separated. Purity was evaluated using a microscope, as 






         The purity of the samples ranged from approximately 70 – 75%. This level of purity 
may not be adequate for more sensitive POC tests that require plasma purity to be 90% or 
greater. RBCs’ presence in plasma is likely because while the fidget spinner is being flicked 
on by one hand, it is being held in place by the other hand. The human hand is prone to 
slight movements, which can throw off the balance of the fidget spinner. The fidget spinner 
is not likely to be perfectly balanced in the first place since it is being held parallel to the 
ground in estimation by the human eye. These movements and loss of balance can disturb 
the centrifugal force and cause the blood to move around in the Eppendorf tube, causing 
some blood to line the walls of the tube. This blood is in contact with the “separated” 
plasma and can cause RBCs to enter the pipette tip when the plasma is being extracted. 
         Another possible cause for the blood lining the wall of the Eppendorf tube on one 
side and decreasing the purity of the plasma is the fact that given the size constraints of the 
Eppendorf tube and the holes on the edge of the fidget spinner, it is difficult to place the 
Eppendorf tubes containing the blood samples at an angle. Since centrifugal force acts 
outward, as seen in Figure 4, the vertical placement of the samples could be a factor causing 
















Figure 4. A schematic to show the direction in which centrifugal force acts. Centrifugal 
force is the seemingly outward force on a mass when it is rotated and looked at from a 
rotating perspective. It acts away from the axis of origin around which an object spin. The 
force can be considered in the case of a rotating device, such as the part holding the samples 
in the device described above.    
 
 
 Based on the purity and yield of the volumes used in this experiment, it would be 
best to use whole blood volumes of 50 – 100 µL when using this method of blood 
separation. When using less than 50 µL of whole blood, there is not enough yield to 
generate adequate amounts of plasma to run more advanced assays that require at least 10 
µL of plasma.17 The ideal whole blood volume for this separation method is 100 µL, as it 
offers the best purity and results in the most final plasma volume. 
4.3 Design Disadvantages 
         Although the fidget spinner can separate plasma from whole blood via manual 





feasible solution. One problem is that although a fidget spinner is simple to operate, holding 
it in place for 10 minutes can be tiring. When this is coupled with the fact that providers in 
the field may have to run multiple tests back-to-back, it becomes clear that use of a fidget 
spinner, although potentially effective in one-off situations where plasma separation is 
required, is not effective for larger scale POC testing. The fact that it is manually held in 
place is not only a burden on the provider, but it is also a possible source of error in the 
blood separation process and does not result in ideal plasma isolation. Due to these design 
disadvantages, it was determined to investigate blood separation methods that may be 
slightly higher in cost but are more viable for long-term usage in LMICs. The next chapter 
will discuss the second design that was used to separate plasma from whole blood. 
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CHAPTER 5: MOTOR-BASED SEPARATION DEVICE 
5.1 Design Description and Justification for Selection 
         For the second device, it was decided to continue relying on centrifugal force as the 
main mechanism for blood separation. In this design however, the object holding the 
samples (a 3D printed part) would be spun using a DC motor instead of being spun 
manually. The 12-volt DC motor is powered by batteries and controlled by a simple on/off 
switch. A 3D printed sample holder is attached to the spinning shaft of the motor and the 
motor itself is placed in a holder to keep it stable while it is on. The positive lead of the 
motor is connected to a switch that controls the flow of current through the circuit. While 
this design is more expensive the previous design described in Chapter 4, it offers many 
advantages that make it more viable for potential use in the field. 
 
Figure 5. The circuit consists of a battery power source, an optional resistor, an on/off 
switch, and the DC motor. The resistor can be placed to decrease the current running 
through the circuit, thus prolonging the battery’s life. The switch can toggle between on 
and off. When the switch is on and the circuit is closed, the motor will begin to spin 
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One advantage of this design is its ease of use and low operation effort. To run 
samples on this device, Eppendorf tubes with a diameter of 0.7 mm must be placed in the 
sample holder, and the switch simply turned on. This will start the motor, and the device 
can be left alone until it is time to turn off the switch and collect the samples. Operation of 
this device requires little training and requires less physical attention than the fidget 
spinner. The automated spinning of the motor would allow a healthcare worker or provider 
to have free hands while the device is running. 
         The automation of the device offers another advantage over the first proposed 
design. It limits the potential for human error. The motor, as long as it is connected to fully 
functioning batteries, will run smoothly and evenly while the circuit is closed. Since the 
3D printed sample holder is fixed rigidly onto the motor, and the motor is secured firmly 
in its holder, there is little to no movement of the spinner while it is running. This limits 
the threat of human movement interfering with the constant application of centrifugal force. 
         Another aspect of this design that helped improve the purity of obtained plasma is 
the angling of the Eppendorf tube holding sockets. The holes in the sample holder were cut 
at a 45° angle, allowing the blood-containing samples to sit slightly slanted. This eliminated 
the problem of whole blood lining along the walls of the tube, as was seen with the first 
device design. Since centrifugal force acts outwards from the center of a circle, aligning 
the sample slightly horizontally allows for a more pronounced separation of RBCs from 
plasma. 
         This design also limits the use of disposables. The only disposables used to separate 
plasma from whole blood with this device are the Eppendorf tubes. Paper-based separation 
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methods, although inexpensive, are not reusable after their first use whereas this device 
does not require replacement of its parts until the battery dies. We will discuss the battery 
life of this device in an upcoming section. 
         Lastly, the simplicity of this device’s parts and circuitry makes it less susceptible 
to failure in the field. There are at most, four components to the circuit: 1) a battery source, 
2) an on/off switch, 3) the DC motor, and 4) an optional resistor that will limit the current 
flow through the circuit. These few components can easily be housed within the device 
while keeping the device itself small and portable. The sample holder can also be replaced 














         
 
Figure 6. The three parts shown in this figure make up the mechanical structure of the 
motorized spinner. A) Bottom view of the spinner. This is the part the holds the blood 
samples as they turn. B) Top view of the spinner. The four holes are where the Eppendorf 
tubes are placed. They are slanted at 45° to maximize the use of centrifugal force. C) A top 
angled view of the motor holder. The motor fits into the hole on top of the structure. The 
space below is used to house batteries and wires (when closed and secured). D) Top view 
of the motor holder. Contains a slot to allow for wires from the power source to connect to 
the positive and negative leads of the motor. E) Side view of the motor. The bottom (shown 
on the left here) contains the positive and negative lead that are exposed through the slot 







5.2 Results and Discussion for Motorized Spinner 
         Blood separation using the motorized spinner was tested with the same sample 
volumes used in Chapter 4: 25 µL, 50 µL, 75 µL, and 100 µL. The motorized spinner was 
able separate plasma with a yield and purity comparable to that of a centrifuge at all four 
sample volume levels. The figures below show the plasma yield and purity obtained from 







Figure 7. A) Percent yield of plasma with whole blood loaded onto the motorized spinner 
at volumes of 25, 50, 75, and 100 µL with n = 10. This sample was spun for 10 minutes 
before being stopped and separated. B) Purity of plasma with whole blood loaded onto the 
fidget spinner at volumes of 25, 50, 75, and 100 µL with n = 10. This sample was spun for 
10 minutes before being stopped and separated. Purity was evaluated using a microscope, 





         The results indicate that this device is capable of separating plasma with high 
efficiency. The plasma has high purity, making it viable for use in any plasma based POCT. 
The device also had high yield which can be advantageous for many reasons. As we 
discussed earlier, pooling plasma before running POCTs can be helpful since some tests 
require exact amounts of plasma. By collecting a large amount of plasma from a given 
whole blood sample, the provider is more likely to be ensured that they have enough plasma 
to run an assay. Also, pooling large amounts of plasma can allow for providers or 
healthcare workers to run multiple tests at once. Often times, when patients come to a 
clinic, they may be exhibiting symptoms that could relate to a variety of diseases. It is 
important to test for multiple diseases to know which one a patient has. It is also possible 
that patients can be coinfected with more than one disease. In that case, it is even more 
essential that multiple tests are performed, and all the conditions of a patient are discovered 
to provide proper treatment. Coinfected patients often need specialized therapy to account 
for unwanted side effects from interfering treatments. 
         Tests on this device and its circuitry were performed to determine the battery life. 
Various resistors were used to evaluate how they affected the current flowing through the 
circuit, and how that, in turn, affected the performance of the device. The table below 
shows how incorporating different resistors and different battery types into the circuit will 




Resistance (ohms) Current (A) Battery Life  
Two 9V, 4 AA 
(Hours) 
Does blood separate after 10 
minutes? (Y/N) 
0 0.730 0.84, 2.74 Y 
3.9 0.484 1.28, 4.13 Y 
6.8 0.418 1.48, 4.78 Y 
12 0.312 1.99, 6.41 Y 
18 0.267 2.32, 7.49 Y 
22 0.222 2.79, 9.01 Y 
33 0.201 3.08, 9.95 N 
         
Table 1. Analysis of how adding a resistor improves blood battery life. Two different 
battery power sources were considered. The first is two 9V batteries in parallel, which has 
a capacity of 620 mAh. The second is four 1.5V AA batteries in series, which have a 
capacity of 2000 mAh. The devices ability to separate plasma from whole blood was also 
observed and recorded. 
 





It was determined that using a resistor of 22 ohms would be optimal in preserving 
battery life while still ensuring efficient separation of plasma from whole blood. The type 
of batteries used to power the motor can also affect battery/device life. While testing with 
this device, two 9-volt batteries connected in parallel were used to power the circuit. This 
power source had a capacity of 620 mAh. However, using four 1.5-volt batteries in series 
to power the circuit offers the potential for longer battery life. 1.5-volt batteries typically 
have a higher capacity of about 2000 mAh. Changing the power source setup provides the 
 
 29 
device with improved battery life. The motor requires 6 – 12 volts to run, so using four 1.5-
volt batteries meets that specification. 
5.3 Cost and Feasibility of Device 
         The use of electrical components in this device makes it more expensive than some 
other LMIC medical field technologies. However, if it is able to perform efficiently for a 
long period of time, the cost could be worth it. Below is the estimated cost of the device 
based on its parts: 
 
Part Cost (USD) 
12V DC motor 6.89 
Two 9V batteries/4 AA batteries 7.99/4.99 




Table 2. The cost of one motorized spinner device is determined by using the costs of it 
parts. The cost of the batteries and the motor are directly taken from retail pricing. The cost 
of the PLA plastic and wiring/electronics were estimated by determining how much a bulk 
amount costs and approximating how much was used to build the device. 
 
         The total cost of this device can range from USD 13.48 – 16.48. While it has a 
higher upfront cost than other blood separation methods, it’s efficiency in separating 
plasma from whole blood and extended battery life make it a more economical decision in 




5.4 Disadvantages and Potential Pitfalls of Device 
         There are some disadvantages to this device, however, that should be addressed. 
One problem is that although the design of the circuit is relatively basic, there is no 
guarantee that problems with the device can be addressed if a fixable issue arises. 
Healthcare workers and providers cannot be assumed to be trained with electronics and 
will likely not find a broken device useful or worth fixing while in the field. Currently, 
there is no back up system or alternative associated with the device if it breaks other than 
fixing or replacing the broken parts. While fixing broken parts may seem straightforward, 
there may be many infrastructural, human, and timing barriers to getting the issues fixed. 
It would be beneficial to find more ways to make the device and its components secure and 
less likely to be damaged. 
         Another potential pitfall of this device is that if it is left running while not being 
used, that could quickly drain the battery and decrease battery life. It is important to make 
sure the device is used for its intended purposes and use for unintended purposes is limited. 
This can be done by implementing a simple timer switch that will turn off after a single 
separation cycle has been performed. This will ensure the viability of this device’s use in 
the field for the expected amount of time. 
5.5 Next Steps 
         One important next step in validating this device as feasible would be to test plasma 
samples obtained from this separation device on POCTs. Plasma and whole blood obtained 
from the separation device would be spiked with various levels of an analyte of interest, 
and then the plasma would be run on a diagnostic test for that analyte. If measurements 
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and/or signals from the diagnostic test were reported as expected, it would validate our 
blood separation device’s performance in the lab. 
         The next step would be to validate the device in the field. To start, this would be 
done by taking the device to colleagues who are experienced with how testing is done in 
the field with patients at the POC. The level of ease or difficult with which they are able to 
implement the device and their feedback will give us an idea of what kind of design changes 
may need to be made. This step is crucial, as frontline workers will be the ones primarily 
handling the device, so their input must be taken into account when designing a device for 
their use. 
 Finally, it will also be imperative to ensure the safety of this design. This could be 
done by designing a compartment underneath the platform in Figure 6C that will house the 
batteries and wires that power the motor. It will then have to be ensured that this device 






         Separating plasma from whole blood is an essential requirement for many POCTs. 
In this thesis, we proposed two methods for separating plasma from whole blood in LMICs 
at the POC. The first version of the design included just a fidget spinner, which held blood 
samples in its arms and was manually spun by the user. This method exhibited some yield 
of around 40% over most blood sample volumes and a purity of 65 – 75%. These results 
were improved upon in the second version of our blood separation system in which a DC 
motor was used to spin a 3D printed sample holder. Plasma from obtained from this method 
of blood separation had around 90% yield and 95% purity, which is comparable to results 
obtained from a centrifuge. 
         Version 2 of our blood separation system has shown promising potential to be 
approved for field use. The high plasma yield obtained from this device means that enough 
plasma can be collected to run multiple POCTs as well as POCTs that require specific 
amounts of plasma. The high purity rates indicate that assays that are run using plasma 
collected via this device are unlikely to see interference due to hemoglobin or RBC lysis. 
However, this device must still be validated in the lab and in the field by POC providers 
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